ReviewProstate cancer and prostatic diseases2021

Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies.

Matthew K Labriola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.